A meta-analysis of the association between calprotectin and the severity of COVID-19 - 02/03/22
Doi : 10.1016/j.jinf.2022.01.022
Qin Mao a, $, Chunyi Wang a, $, Wen Wen a, $, Mengyun Zhou b, $, Jiake Tang a, Chen Chen a, Yongran Cheng c, Qi Wu a, Xingwei Zhang a, Zhanhui Feng d, ⁎ 
, Mingwei Wang a, ⁎
, Mingwei Wang a, ⁎ a Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 310015, China
b Department of Molecular & Cellular Physiology, Shinshu University School of Medicine,3900803, Japan
c School of Public Health, Hangzhou Medical College, Hangzhou, 311300, China
d Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China
⁎Corresponding authors.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)is constantly ravaging the world. |
• | Many inflammatory factors(such as C-reactive protein, ferritin, and d-dimer)have been reported as poor prognosis predictors for patients with COVID-19. |
• | The role of serum calprotectin levels in severe COVID-19 is controversial. Our results of meta-analysis support calprotectin as an important COVID-19 biomarker, and its clinical use in predicting disease severity. |
Plan
© 2022
Publié par Elsevier Masson SAS.
Vol 84 - N° 3
P. e31-e33 - mars 2022 Retour au numéro
Article précédent
- SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
- Aayush Gupta, Rahul Bhoyar, Shahzad Mirza, Bani Jolly, Vigneshwar Senthivel, Afra Shamnath, Mohit Kumar Divakar, Mohamed Imran, Vishu Gupta, Srashti Jyoti Agrawal, Sahjid Mukhida, Sridhar Sivasubbu, Vinod Scaria
- Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients
- Didier DUCLOUX, Jamal BAMOULID, Melchior CHABANNES, Mathilde COLLADANT, Abdulaziz MUNSHI, Caroline ROUBIOU, Jean SEIBEL, Amine TACHIKART, Maria YANNARAKI, Thomas CREPIN, Cécile COURIVAUD
Bienvenue sur EM-consulte, la référence des professionnels de santé.